Cargando…

Molecular Modelling Studies on Pyrazole Derivatives for the Design of Potent Rearranged during Transfection Kinase Inhibitors

RET (rearranged during transfection) kinase, one of the receptor tyrosine kinases, plays a crucial role in the development of the human nervous system. It is also involved in various cell signaling networks responsible for the normal cell division, growth, migration, and survival. Previously reporte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhujbal, Swapnil P., Keretsu, Seketoulie, Cho, Seung Joo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865942/ https://www.ncbi.nlm.nih.gov/pubmed/33525725 http://dx.doi.org/10.3390/molecules26030691

Ejemplares similares

Rational approach toward COVID-19 main protease inhibitors via molecular docking, molecular dynamics simulation and free energy calculation
por: Keretsu, Seketoulie, et al.
Publicado: (2020)

Computational study of paroxetine-like inhibitors reveals new molecular insight to inhibit GRK2 with selectivity over ROCK1
por: Keretsu, Seketoulie, et al.
Publicado: (2019)

Designing of the N-ethyl-4-(pyridin-4-yl)benzamide based potent ROCK1 inhibitors using docking, molecular dynamics, and 3D-QSAR
por: Ghosh, Suparna, et al.
Publicado: (2021)

Computer aided designing of novel pyrrolopyridine derivatives as JAK1 inhibitors
por: Keretsu, Seketoulie, et al.
Publicado: (2021)

Molecular Modeling Studies of N-phenylpyrimidine-4-amine Derivatives for Inhibiting FMS-like Tyrosine Kinase-3
por: Ghosh, Suparna, et al.
Publicado: (2021)

Molecular Modeling Study of c-KIT/PDGFRα Dual Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
por: Keretsu, Seketoulie, et al.
Publicado: (2020)

Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking
por: Bhujbal, Swapnil P., et al.
Publicado: (2022)

An Intriguing Purview on the Design of Macrocyclic Inhibitors for Unexplored Protein Kinases through Their Binding Site Comparison
por: Bhujbal, Swapnil P., et al.
Publicado: (2023)

An Innovative Approach to Address Neurodegenerative Diseases through Kinase-Targeted Therapies: Potential for Designing Covalent Inhibitors
por: Bhujbal, Swapnil P., et al.
Publicado: (2023)

Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies
por: Bhujbal, Swapnil P., et al.
Publicado: (2022)

Molecular docking of 1H-pyrazole derivatives to receptor tyrosine kinase and protein kinase for screening potential inhibitors
por: Chandra,, et al.
Publicado: (2014)

Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach
por: Bhujbal, Swapnil P., et al.
Publicado: (2021)

Design, synthesis and molecular modelling studies of some pyrazole derivatives as carbonic anhydrase inhibitors
por: Dizdaroglu, Yazgı, et al.
Publicado: (2019)

The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies
por: Nitulescu, George Mihai, et al.
Publicado: (2023)

Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors
por: Ali, Sahar A., et al.
Publicado: (2020)

Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease
por: Yan, Ning, et al.
Publicado: (2022)

Kinase Inhibitory Activities and Molecular Docking of a Novel Series of Anticancer Pyrazole Derivatives
por: Nossier, Eman S., et al.
Publicado: (2018)

Design, Synthesis and Mechanistic Studies of Novel Isatin-Pyrazole Hydrazone Conjugates as Selective and Potent Bacterial MetAP Inhibitors
por: Irfan, Iram, et al.
Publicado: (2022)

2D-QSAR Modeling and Molecular Docking Studies on 1H-Pyrazole-1-carbothioamide Derivatives as EGFR Kinase Inhibitors
por: Hajalsiddig, Tawassl T. H., et al.
Publicado: (2020)

Synthesis of 3,5-Bis(trifluoromethyl)phenyl-Substituted Pyrazole Derivatives as Potent Growth Inhibitors of Drug-Resistant Bacteria
por: Alkhaibari, Ibrahim S., et al.
Publicado: (2021)

Design and synthesis of amino acid derivatives of substituted benzimidazoles and pyrazoles as Sirt1 inhibitors
por: Purushotham, Nikil, et al.
Publicado: (2022)

Design, Synthesis, Biological Evaluation and In Silico Studies of Pyrazole-Based NH(2)-Acyl Oseltamivir Analogues as Potent Neuraminidase Inhibitors
por: Ye, Jiqing, et al.
Publicado: (2021)

Design of transfections: Implementation of design of experiments for cell transfection fine tuning
por: Mancinelli, Sara, et al.
Publicado: (2021)

Design, and Synthesis of 4-[4-Formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic Acid Derivatives as Potent Growth Inhibitors of Drug-Resistant Staphylococcus aureus.
por: Alnufaie, Rawan, et al.
Publicado: (2020)

Imidazopyridazines as potent inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1): Preparation and evaluation of pyrazole linked analogues()
por: Large, Jonathan M., et al.
Publicado: (2013)

Rearranged During Transfection Fusions in Non-Small Cell Lung Cancer
por: O’Leary, Connor, et al.
Publicado: (2019)

Is There Any Mosaicism in REarranged During Transfection Variant in Hirschsprung Disease’s Patients?
por: Iskandar, Kristy, et al.
Publicado: (2022)

Novel Anthraquinone-based Derivatives as Potent Inhibitors for Receptor Tyrosine Kinases
por: Stasevych, M., et al.
Publicado: (2015)

Design, Synthesis and Anticandidal Evaluation of Indazole and Pyrazole Derivatives
por: Rodríguez-Villar, Karen, et al.
Publicado: (2021)

Fragment-Based Lead Generation of 5-Phenyl-1H-pyrazole-3-carboxamide Derivatives as Leads for Potent Factor Xia Inhibitors
por: Wei, Qunchao, et al.
Publicado: (2018)

Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents
por: Alnufaie, Rawan, et al.
Publicado: (2020)

Design, efficient synthesis and molecular docking of some novel thiazolyl-pyrazole derivatives as anticancer agents
por: Sayed, Abdelwahed R., et al.
Publicado: (2019)

Pyrazole and Triazole Derivatives as Mycobacterium tuberculosis UDP-Galactopyranose Inhibitors
por: Ahmed, Dalia M., et al.
Publicado: (2022)

Design and Synthesis of Pyrazole-3-one Derivatives as Hypoglycaemic Agents
por: Datar, Prasanna A., et al.
Publicado: (2015)

Design, Synthesis and Fungicidal Activities of Some Novel Pyrazole Derivatives
por: Liu, Xue-Ru, et al.
Publicado: (2014)

Molecular modeling piloted analysis for semicarbazone derivative of curcumin as a potent Abl-kinase inhibitor targeting colon cancer
por: Rodrigues, Fiona C., et al.
Publicado: (2021)

Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors
por: Chu, Guo-Hua, et al.
Publicado: (2009)

Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1H-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor
por: Kim, Jinwoong, et al.
Publicado: (2019)

Comparison of Rearranged During Transfection (RET) Gene Rearrangements in Primary Versus Metastatic Non-Small Cell Lung Cancer (NSCLC)
por: Zhang, Quxia, et al.
Publicado: (2018)

Expanded Access Program Pralsetinib in Advanced Non–Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement
por: Jeon, Youngkyung, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l32a2jjki47tlar0vaia9en4sc